DRUG P/E Ratio
P/E Ratio as of Jun 13, 2025: -73.72
Average-76.69
Median-74.44
Minimum-88.21
Maximum-69.37
-73.72
Past Month+12.78 (14.77%)
The P/E ratio for DRUG is -73.72 as of Jun 13, 2025. This represents a decrease of -6.85% compared to its 12-month average P/E ratio of -79.14. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Bright Minds Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Bright Minds Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Bright Minds Biosciences to industry peers.
Bright Minds Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Bright Minds Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Bright Minds Biosciences to industry peers.
DRUG P/E Ratio Insights
See Bright Minds Biosciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in DRUG
Order type
Buy in
Order amount
Est. shares
0 shares
DRUG P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $28.32 | -75.70 |
| May 1, 2025 | $30.62 | -172.70 |
| Apr 1, 2025 | $36.11 | -203.67 |
| Mar 3, 2025 | $34.92 | -196.95 |
| Feb 3, 2025 | $37.25 | -73.78 |
| Jan 2, 2025 | $41.11 | -81.42 |
DRUG End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -73.72 | +3.34% |
| 2024 | -71.34 | +7,254.64% |
| 2023 | -0.97 | +24.36% |
| 2022 | -0.78 | -78.15% |
| 2021 | -3.57 | — |
FAQs About Bright Minds Biosciences (DRUG) P/E ratio
The latest P/E ratio of DRUG is -73.72, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Bright Minds Biosciences’s last 12-month average P/E ratio is -79.14, compared to its current P/E ratio of -73.72. This reflects a decrease of -6.85%.
Bright Minds Biosciences’s current P/E ratio of -73.72 is lower than its last 12-month average P/E of -79.14. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Bright Minds Biosciences’s average P/E ratio over the last 3 years is -27.17. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Bright Minds Biosciences’s average P/E ratio over the last 5 years is -16.82. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.